Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEMD NASDAQ:BJDX NASDAQ:PFSA NASDAQ:VBIO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$0.58-2.6%$1.46$0.58▼$27.40$1.39M1.41148,981 shs61,237 shsBJDXBluejay Diagnostics$1.03-9.6%$2.58$1.02▼$16.68$1.07M0.888.38 million shs237,193 shsPFSAProfusa$1.71-2.8%$5.12$1.60▼$4,162.50$320K0.46208,788 shs25,686 shsVBIOValion Bio, Inc. Common Stock$0.30+3.8%$0.60$0.25▼$5.60$1.23M1.82396,925 shs6.23 million shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical0.00%-10.05%-34.38%-73.42%-95.82%BJDXBluejay Diagnostics0.00%-28.97%-68.88%-45.76%-84.10%PFSAProfusa0.00%-1.16%-42.03%-88.15%+170,999,900.00%VBIOValion Bio, Inc. Common Stock0.00%-41.19%-48.56%-77.67%-93.13%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$0.58-2.6%$1.46$0.58▼$27.40$1.39M1.41148,981 shs61,237 shsBJDXBluejay Diagnostics$1.03-9.6%$2.58$1.02▼$16.68$1.07M0.888.38 million shs237,193 shsPFSAProfusa$1.71-2.8%$5.12$1.60▼$4,162.50$320K0.46208,788 shs25,686 shsVBIOValion Bio, Inc. Common Stock$0.30+3.8%$0.60$0.25▼$5.60$1.23M1.82396,925 shs6.23 million shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical0.00%-10.05%-34.38%-73.42%-95.82%BJDXBluejay Diagnostics0.00%-28.97%-68.88%-45.76%-84.10%PFSAProfusa0.00%-1.16%-42.03%-88.15%+170,999,900.00%VBIOValion Bio, Inc. Common Stock0.00%-41.19%-48.56%-77.67%-93.13%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical 1.50ReduceN/AN/ABJDXBluejay Diagnostics 1.00SellN/AN/APFSAProfusa 1.00SellN/AN/AVBIOValion Bio, Inc. Common Stock 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest PFSA, AEMD, VBIO, and BJDX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2026AEMDAethlon Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)7/17/2026VBIOValion Bio, Inc. Common Stock Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)6/24/2026BJDXBluejay Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)6/24/2026PFSAProfusa Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 7/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon MedicalN/AN/AN/AN/A$3.11 per shareN/ABJDXBluejay DiagnosticsN/AN/AN/AN/A$8.43 per shareN/APFSAProfusa$100K3.25N/AN/A($542.23) per share0.00VBIOValion Bio, Inc. Common Stock$780K1.58N/AN/A$6.65 per share0.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$7.15M-$14.69N/AN/AN/AN/A-137.73%-105.87%8/12/2026 (Estimated)BJDXBluejay Diagnostics-$6.85M-$11.63N/AN/AN/AN/A-144.27%-115.00%8/19/2026 (Estimated)PFSAProfusa-$35.82M-$4,242.98N/AN/AN/AN/AN/A-1,348.07%N/AVBIOValion Bio, Inc. Common Stock-$8.88M-$6.68N/AN/AN/AN/A-138.10%-63.67%8/17/2026 (Estimated)Latest PFSA, AEMD, VBIO, and BJDX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/19/2026N/ABJDXBluejay Diagnostics-$3,520.00N/AN/AN/AN/AN/A8/17/2026Q2 2026VBIOValion Bio, Inc. Common Stock-$408.00N/AN/AN/A$0.46 millionN/A8/12/2026Q1 2027AEMDAethlon Medical-$0.7850N/AN/AN/AN/AN/A5/14/2026Q1 2026VBIOValion Bio, Inc. Common StockN/A-$2.23N/A-$2.23N/AN/A5/7/2026Q1 2026BJDXBluejay DiagnosticsN/A-$1.95N/A-$1.95N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/ABJDXBluejay DiagnosticsN/AN/AN/AN/AN/APFSAProfusaN/AN/AN/AN/AN/AVBIOValion Bio, Inc. Common StockN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A3.853.85BJDXBluejay DiagnosticsN/A2.812.81PFSAProfusaN/A0.020.02VBIOValion Bio, Inc. Common Stock0.623.313.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%BJDXBluejay Diagnostics18.47%PFSAProfusa9.81%VBIOValion Bio, Inc. Common Stock4.25%Insider OwnershipCompanyInsider OwnershipAEMDAethlon Medical0.71%BJDXBluejay Diagnostics6.10%PFSAProfusa0.76%VBIOValion Bio, Inc. Common Stock2.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical102.37 million2.35 millionNo DataBJDXBluejay Diagnostics91.03 million972,000Not OptionablePFSAProfusa2190,000185,000N/AVBIOValion Bio, Inc. Common Stock104.15 million4.06 millionNot OptionablePFSA, AEMD, VBIO, and BJDX HeadlinesRecent News About These CompaniesValion Bio, Inc.July 22, 2026 | cnn.comUkraine Ministry of Health Accepts Entolimod Dossier for Formal Review Under Regulatory Equivalence PathwayJuly 22, 2026 | prnewswire.comWorld-Premier Cancer Center Sheba Medical Center Selects Entolimod for Clinical Trial, Potentially Expanding Valion Bio into the Multi-Billion-Dollar Neutropenia MarketJuly 20, 2026 | prnewswire.comValion Bio Advances Integrated Biodefense and Immunology Platform Through Continued Government Engagement, Domestic Manufacturing and Oncology ExpansionJuly 14, 2026 | prnewswire.comAFRRI/NIAID Designs Proprietary PBI-BM2.5 Protocol to Evaluate Valion Bio's (NASDAQ: VBIO) Entolimod as the First and Only Treatment for GI-ARSJune 25, 2026 | prnewswire.comVALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROMEMay 19, 2026 | prnewswire.comValion Bio, Inc.: Valion Bio Reports First Quarter 2026 Financial ResultsMay 15, 2026 | finanznachrichten.deValion Bio outlines end-2026 Entolimod GMP validation target as NIAID funds GI-ARS BLA-enabling workMay 14, 2026 | seekingalpha.comValion Bio Inc. (VBIO) Q1 2026 Earnings Call Prepared Remarks TranscriptMay 14, 2026 | seekingalpha.comValion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ PlatformMay 14, 2026 | prnewswire.comVALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTSMay 14, 2026 | prnewswire.comValion Bio to Report First Quarter 2026 Financial Results on May 14, 2026May 11, 2026 | prnewswire.comValion Bio Celebrates Grand Opening of Velocity Bioworks Biomanufacturing Facility in San Antonio, Anchoring Domestic Production of Entolimod™May 6, 2026 | prnewswire.comVALION BIO RECEIVES FIRST FDA-PRECEDENT STUDY PROTOCOL FROM NIAID FOR ENTOLIMOD™; FEDERAL AGENCY TO FULLY FUND BLA-ENABLING IN VIVO PROGRAM AND CO-NAVIGATE FDA SUBMISSIONMay 5, 2026 | prnewswire.comTivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple ...April 23, 2026 | finance.yahoo.comTivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream ModelApril 23, 2026 | prnewswire.comSheryle Bolton Purchases 10,000 Shares of Tivic Health Systems (NASDAQ:TIVC) StockApril 21, 2026 | insidertrades.comTivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7thApril 15, 2026 | prnewswire.comTivic Health Systems, Inc.April 3, 2026 | edition.cnn.comTivic Health Systems (NASDAQ:TIVC) Director Christina Rizopoulos Valauri Acquires 19,000 SharesApril 3, 2026 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePFSA, AEMD, VBIO, and BJDX Company DescriptionsAethlon Medical NASDAQ:AEMD$0.58 -0.02 (-2.63%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$0.61 +0.03 (+4.33%) As of 07/24/2026 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.Bluejay Diagnostics NASDAQ:BJDX$1.03 -0.11 (-9.65%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$1.04 +0.01 (+0.68%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.Profusa NASDAQ:PFSA$1.71 -0.05 (-2.84%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$1.73 +0.02 (+1.23%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.Valion Bio, Inc. Common Stock NASDAQ:VBIO$0.30 +0.01 (+3.85%) As of 07/24/2026 04:00 PM EasternTivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/20- 07/24 Telecom Earnings Reveal a Sector That Finally Looks Healthier AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Defense Earnings Show Readiness Now and Modernization Ahead Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
